University of Pennsylvania

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).

1,423 total trials 199 currently recruiting 982 completed early-phase tilt top decile by trial count

University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.

University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.

Top-decile sponsor footprint

University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,423 total, page 27 of 29

COMPLETED

Ovarian Cancer and Immune Response to Flu Vaccine

NCT00478387

COMPLETED Phase 4

Effects of Chantix on Relapse Prevention for Smoking Cessation

NCT00948649

COMPLETED NA

The Effects of Obesity and Obstructive Sleep Apnea on Inflammation and Heart Disease

NCT00371293

COMPLETED NA

Neural Effects of Mindfulness Training on Attention

NCT00379210

TERMINATED Phase 2

A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension

NCT00384865

COMPLETED Phase 2

Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal

NCT00480441

COMPLETED NA

Warfarin and Non-Steroidal Anti-Inflammatory Drugs (NSAID) Customized Alert

NCT00880932

COMPLETED NA

The Role of Partial Reinforcement in the Long Term Management of Insomnia

NCT00662155

COMPLETED Phase 3

Treatment of Insomnia in Elderly Sleep Apnea Patients With Ramelteon (TAK 375)

NCT01048242

COMPLETED Phase 2

Addiction Treatment in Russia: Oral vs. Naltrexone Implant

NCT00218426

COMPLETED Phase 2

Cognitive Therapy for Negative Symptoms and Functioning

NCT00350883

COMPLETED NA

Think Health! A Personal Weight Management Program

NCT00959608

COMPLETED Phase 2

Effect of OPC Factor on Energy Levels

NCT00318019

COMPLETED NA

Use of Chewing Gum to Facilitate Appetite Control and Weight Loss

NCT00871676

COMPLETED

Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis

NCT00315393

COMPLETED

Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis

NCT00315471

COMPLETED Phase 4

Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome

NCT01035073

COMPLETED

Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa

NCT00315406

COMPLETED

Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis

NCT00315497

TERMINATED

Measuring Electrical Resistance of Different Tissues on the Outer Surface of the Heart

NCT00291174

COMPLETED

Assessing Fertility Potential in Female Cancer Survivors

NCT01143844

COMPLETED Phase 1

Gene Therapy for Pleural Malignancies

NCT00299962

COMPLETED

Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their Caregivers

NCT00294307

COMPLETED Phase 2

Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

NCT00654238

COMPLETED Phase 3

Acupuncture for Promotion of Timely Delivery

NCT00379327

COMPLETED Phase 2

A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) Metabolism

NCT00327002

COMPLETED Phase 1

Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV

NCT00295477

COMPLETED Phase 2

Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL

NCT00300365

COMPLETED Phase 4

Endophenotype for Alcohol Misuse in Healthy Minority Populations

NCT00256451

COMPLETED NA

Depot Naltrexone Treatment of Opioid Dependent Parolees

NCT00756990

COMPLETED Phase 4

Chamomile Therapy for Generalized Anxiety

NCT00645983

COMPLETED Phase 2

Curcuminoids for the Treatment of Chronic Psoriasis Vulgaris

NCT00235625

COMPLETED Phase 2

Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression

NCT00655057

TERMINATED Phase 4

Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant

NCT00596947

COMPLETED Phase 3

Testing the Effects of Telehealth Monitoring on Rehospitalization and Self Care for Heart Failure Patients in Home Care

NCT00300261

COMPLETED Phase 4

Luteal Phase FSH in the IVF Poor Responder

NCT00225433

COMPLETED Phase 1

Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients

NCT00478452

COMPLETED Phase 2

The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study

NCT00400231

COMPLETED Phase 2

Insulin Resistance and Testosterone in Women

NCT00123110

COMPLETED NA

Postoperative Dietary Counseling After Bariatric Surgery

NCT00125073

COMPLETED Phase 4

Black Cohosh as Alternative Therapy for Treating Menopause-Related Anxiety

NCT00120458

COMPLETED NA

Managed Problem Solving to Increase Treatment Adherence in Individuals With HIV

NCT00130273

TERMINATED NA

Curcumin for the Chemoprevention of Colorectal Cancer

NCT00118989

COMPLETED NA

Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea

NCT00194376

COMPLETED Phase 1

Effectiveness of Cognitive Therapy for Suicide Attempters With Drug Dependence Disorder

NCT00218725

COMPLETED NA

Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women

NCT00676026

COMPLETED NA

Comparison of Two Medication Adherence Strategies to Improve Asthma Treatment Adherence

NCT00115323

COMPLETED Phase 1

Cognitive Therapy for Suicidal Older Men in Primary Care Settings

NCT00149773

COMPLETED

Human Papillomavirus (HPV) Infection in Pregnancy

NCT00194311

COMPLETED NA

Financial Incentives for Smoking Cessation

NCT00128375

← Previous Page 27 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 182
Phase 2 157
Phase 3 43
Phase 4 87

What is open in the University of Pennsylvania pipeline

199 recruiting of 1,423 indexed (14% open); 982 completed (69%).

Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).

Top condition: Obesity (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.